Form DEF 14C - Other definitive information statements:
SEC Accession No. 0001013596-10-000050
Filing Date
2010-05-04
Accepted
2010-05-03 18:33:20
Documents
2
Period of Report
2010-05-04
Effectiveness Date
2010-05-04

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE SCHEDULE 14C fm14c_def.htm DEF 14C 206947
2 GRAPHIC img1.gif GRAPHIC 133
  Complete submission text file 0001013596-10-000050.txt   208931
Mailing Address 6100 ROYALMOUNT AVENUE MONTREAL A8 H4P 2R2
Business Address 6100 ROYALMOUNT AVENUE MONTREAL A8 H4P 2R2 514-496-5197
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: DEF 14C | Act: 34 | File No.: 000-52898 | Film No.: 10794422
SIC: 8742 Services-Management Consulting Services